UBS Group’s AstraZeneca AZNH Stock Holding History

UBS Group’s Portfolio AZNH Stock Details AZNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-107	Closed	-$4.5K	–	10892
2024 Q4	$4.5K	Buy	+107	New	+$4.88K	﹤0.01%	8752

Other funds holding AZNH

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group's AZNH Position: Q1 2025 in Review

UBS Group sold out of AstraZeneca (AZNH) in Q1 2025, closing a stake of 107 shares — an estimated $4.5K sold.

UBS Group first reported a position in AZNH in Q4 2024 and held it in 1 quarter. The position peaked at $4.5K in Q4 2024. 1 fund tracked by Wall St. Rank holds AZNH as of Q1 2025.

UBS Group reported no remaining AstraZeneca position as of Q1 2025 after selling out during the quarter.
UBS Group sold 107 AstraZeneca shares in Q1 2025, an estimated $4.5K.
UBS Group first reported a position in AstraZeneca in Q4 2024 and held it in 1 quarter.
UBS Group's AstraZeneca position peaked at $4.5K in Q4 2024.
1 fund tracked by Wall St. Rank held AstraZeneca as of Q1 2025.

Based on UBS Group's 13F filing for Q1 2025, filed 13 May 2025.